DK0806952T3 - Progesteronantagonister til fremstillingen af lægemidler til behandling af dysfunktionelle uterine blødninger - Google Patents
Progesteronantagonister til fremstillingen af lægemidler til behandling af dysfunktionelle uterine blødningerInfo
- Publication number
- DK0806952T3 DK0806952T3 DK95919986T DK95919986T DK0806952T3 DK 0806952 T3 DK0806952 T3 DK 0806952T3 DK 95919986 T DK95919986 T DK 95919986T DK 95919986 T DK95919986 T DK 95919986T DK 0806952 T3 DK0806952 T3 DK 0806952T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- drugs
- manufacture
- uterine bleeding
- dysfunctional uterine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP1995/000394 WO1996023503A1 (de) | 1995-02-02 | 1995-02-02 | Progesteronantagonisten für die herstellung von arzneimitteln zur behandlung von dysfunktionellen uterinen blutungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0806952T3 true DK0806952T3 (da) | 2003-06-16 |
Family
ID=8165951
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK95919986T DK0806952T3 (da) | 1995-02-02 | 1995-02-02 | Progesteronantagonister til fremstillingen af lægemidler til behandling af dysfunktionelle uterine blødninger |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6451780B1 (da) |
| EP (1) | EP0806952B1 (da) |
| JP (1) | JPH10512889A (da) |
| KR (1) | KR100370908B1 (da) |
| AT (1) | ATE235907T1 (da) |
| AU (1) | AU714959B2 (da) |
| CA (1) | CA2186953C (da) |
| DE (1) | DE59510626D1 (da) |
| DK (1) | DK0806952T3 (da) |
| ES (1) | ES2196063T3 (da) |
| FI (1) | FI117850B (da) |
| HU (1) | HU226276B1 (da) |
| MX (1) | MX9603889A (da) |
| NO (1) | NO964155D0 (da) |
| NZ (1) | NZ287024A (da) |
| PL (1) | PL316533A1 (da) |
| PT (1) | PT806952E (da) |
| SK (1) | SK282570B6 (da) |
| UA (1) | UA37259C2 (da) |
| WO (1) | WO1996023503A1 (da) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8193252B1 (en) * | 1999-08-31 | 2012-06-05 | Bayer Pharma AG | Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological disorders |
| CA2382580C (en) | 1999-08-31 | 2009-05-19 | Jenapharm Gmbh & Co. Kg | Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological disorders |
| US20020176893A1 (en) * | 2001-02-02 | 2002-11-28 | Wironen John F. | Compositions, implants, methods, and kits for closure of lumen openings, repair of ruptured tissue, and for bulking of tissue |
| US6685626B2 (en) | 2001-02-02 | 2004-02-03 | Regeneration Technologies, Inc. | Compositions, devices, methods, and kits for induction of adhesions |
| US20080182841A1 (en) * | 2001-10-29 | 2008-07-31 | Levine Howard L | Vaginally administered anti-dysrhythmic agents for treating pelvic pain |
| US7556150B2 (en) * | 2004-06-07 | 2009-07-07 | Duramed Pharmaceuticals, Inc. | Dispenser for progestin used for acute and maintenance treatment of DUB |
| US8173626B2 (en) * | 2006-03-08 | 2012-05-08 | Danco Laboratories Llc | Methods, dosing regimens and medications using anti-progestational agents for the treatment of disorders |
| JP5785392B2 (ja) * | 2007-04-20 | 2015-09-30 | プレグレム エスアーＰｒｅｇｌｅｍ Ｓ．Ａ． | 過剰子宮出血の治療におけるプロゲステロンアンタゴニストおよび選択的プロゲステロンモジュレーター |
| US20090118253A1 (en) * | 2007-11-05 | 2009-05-07 | Repros Therapeutics Inc. | Compositions and methods for treating dysfunctional uterine bleeding |
| US8299050B2 (en) * | 2008-01-29 | 2012-10-30 | Laboratoire Hra-Pharma | Method for treating uterine fibroids |
| TWI477276B (zh) * | 2008-04-28 | 2015-03-21 | Repros Therapeutics Inc | 抗黃體素給藥方案 |
| TWI539953B (zh) * | 2008-04-28 | 2016-07-01 | 瑞波若斯治療學公司 | 用於治療乳癌之組成物和方法 |
| DE102009034366A1 (de) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
| DE102009034367A1 (de) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten |
| DE102009034368A1 (de) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
| DE102009034526A1 (de) | 2009-07-21 | 2011-02-10 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten |
| DE102010007719A1 (de) | 2010-02-10 | 2011-08-11 | Bayer Schering Pharma Aktiengesellschaft, 13353 | Progesteronrezeptorantagonisten |
| DE102010007722A1 (de) | 2010-02-10 | 2011-08-11 | Bayer Schering Pharma Aktiengesellschaft, 13353 | Progesteronrezeptorantagonisten |
| EP2545922A1 (en) * | 2011-07-12 | 2013-01-16 | PregLem S.A. | Treatment of excessive menstrual bleeding associated with uterine fibroids |
| CA2872644A1 (en) | 2012-05-31 | 2013-12-05 | Repros Therapeutics Inc. | Formulations and methods for vaginal delivery of antiprogestins |
| ES2688821T3 (es) | 2012-11-02 | 2018-11-07 | Repros Therapeutics Inc. | Métodos y composiciones para tratar afecciones dependientes de la progesterona |
| EP3394079A4 (en) | 2015-12-23 | 2019-08-21 | Oric Pharmaceuticals, Inc. | INHIBITORS OF GLUCOCORTICOIDREZEPTORS |
| AU2016377702B2 (en) | 2015-12-23 | 2021-03-11 | Oric Pharmaceuticals, Inc. | Inhibitors of glucocorticoid receptor |
| US11110103B2 (en) | 2015-12-23 | 2021-09-07 | Oric Pharmaceuticals, Inc. | Inhibitors of glucocorticoid receptor |
| PT3523315T (pt) | 2016-10-07 | 2021-04-29 | Oric Pharmaceuticals Inc | Inibidor de recetor de glucocorticoide |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1918092A (en) * | 1992-05-06 | 1993-11-29 | Medical College Of Hampton Roads, The | Minimizing progestin associated breakthrough bleeding |
| US5622943A (en) | 1992-05-06 | 1997-04-22 | The Medical College Of Hampton Roads | Minimizing progestin associated breakthrough bleeding |
-
1995
- 1995-02-02 EP EP95919986A patent/EP0806952B1/de not_active Expired - Lifetime
- 1995-02-02 AU AU25611/95A patent/AU714959B2/en not_active Ceased
- 1995-02-02 MX MX9603889A patent/MX9603889A/es not_active IP Right Cessation
- 1995-02-02 HU HU9602668A patent/HU226276B1/hu not_active IP Right Cessation
- 1995-02-02 UA UA96104324A patent/UA37259C2/uk unknown
- 1995-02-02 PT PT95919986T patent/PT806952E/pt unknown
- 1995-02-02 SK SK1219-96A patent/SK282570B6/sk unknown
- 1995-02-02 PL PL95316533A patent/PL316533A1/xx unknown
- 1995-02-02 DE DE59510626T patent/DE59510626D1/de not_active Expired - Lifetime
- 1995-02-02 CA CA002186953A patent/CA2186953C/en not_active Expired - Lifetime
- 1995-02-02 DK DK95919986T patent/DK0806952T3/da active
- 1995-02-02 WO PCT/EP1995/000394 patent/WO1996023503A1/de active IP Right Grant
- 1995-02-02 JP JP8523189A patent/JPH10512889A/ja not_active Withdrawn
- 1995-02-02 KR KR1019960705470A patent/KR100370908B1/ko not_active IP Right Cessation
- 1995-02-02 ES ES95919986T patent/ES2196063T3/es not_active Expired - Lifetime
- 1995-02-02 AT AT95919986T patent/ATE235907T1/de active
-
1996
- 1996-08-01 FI FI963049A patent/FI117850B/fi not_active IP Right Cessation
- 1996-10-01 NZ NZ287024A patent/NZ287024A/en not_active IP Right Cessation
- 1996-10-01 NO NO964155A patent/NO964155D0/no not_active Application Discontinuation
-
2000
- 2000-07-12 US US09/615,060 patent/US6451780B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2196063T3 (es) | 2003-12-16 |
| KR100370908B1 (ko) | 2003-04-10 |
| ATE235907T1 (de) | 2003-04-15 |
| FI117850B (fi) | 2007-03-30 |
| NZ287024A (en) | 2001-03-30 |
| KR970704451A (ko) | 1997-09-06 |
| NO964155L (no) | 1996-10-01 |
| FI963049A (fi) | 1996-10-01 |
| WO1996023503A1 (de) | 1996-08-08 |
| EP0806952B1 (de) | 2003-04-02 |
| US6451780B1 (en) | 2002-09-17 |
| HUT75930A (en) | 1997-05-28 |
| AU2561195A (en) | 1996-08-21 |
| CA2186953A1 (en) | 1996-08-08 |
| FI963049A0 (fi) | 1996-08-01 |
| PL316533A1 (en) | 1997-01-20 |
| MX9603889A (es) | 1997-04-30 |
| CA2186953C (en) | 2009-11-10 |
| HU9602668D0 (en) | 1996-11-28 |
| UA37259C2 (uk) | 2001-05-15 |
| PT806952E (pt) | 2003-08-29 |
| DE59510626D1 (de) | 2003-05-08 |
| NO964155D0 (no) | 1996-10-01 |
| JPH10512889A (ja) | 1998-12-08 |
| HU226276B1 (en) | 2008-07-28 |
| EP0806952A1 (de) | 1997-11-19 |
| AU714959B2 (en) | 2000-01-13 |
| SK282570B6 (sk) | 2002-10-08 |
| SK121996A3 (en) | 1997-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0806952T3 (da) | Progesteronantagonister til fremstillingen af lægemidler til behandling af dysfunktionelle uterine blødninger | |
| EE05287B1 (et) | Tsklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon | |
| DE69531998D1 (de) | Steroidrezeptor-modulator verbindungen und methoden | |
| BRPI0113286B8 (pt) | pirazóis substituídos e composição farmacêutica compreendendo os mesmos. | |
| HUP9700603A1 (hu) | Gyógyászati készítmény véralvadási zavarok kezelésére | |
| TR199901174T2 (xx) | Yeni heterosiklilmetil-ikameli pirazol t�revleri. | |
| NO994850L (no) | Farmakologiske midler | |
| TR200200768T2 (tr) | Yeni kuinüklidin türevleri ve bunu içeren ilaç bileşimleri | |
| YU7797A (sh) | Kombinovana terapija za osteoporozu | |
| ATE390917T1 (de) | Prävention und behandlung von skeletterkrankungen mit ep2 subtyp selektiven prostaglandin e2 agonisten | |
| DE69938935D1 (de) | Zyklische conotoxin-peptide | |
| DK0979079T3 (da) | Anvendelse af tetrahydropyridinderivater til fremstilling af lægemidler til behandling af sygdomme, der medförer en demyelinisering | |
| NO164656C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktivt 1-(4-amionfenyl)-4-methyl-7,8-methylendioxy-3,4-dihydro-5h-2,3-benzodiazepin. | |
| PT1140031E (pt) | Preparacao farmaceutica de libertacao controlada com mesilato de tilidina como substancia activa | |
| EA199800692A1 (ru) | Изолируемые смеси из семян eugenia jambolana lamarck, способы их получения, способ получения оксамата натрия, лекарственные средства для профилактики и лечения диабета и применение указанных смесей, их компонентов и оксамата натрия для получения этих лекарственных средств | |
| ATE291908T1 (de) | Ibuprofen-wirkstoffzubereitung | |
| TR199900548A3 (tr) | Düsük kesme kuvvetli taneleme kullanilarak dozaj birimlerinin yapimi. | |
| PT1107793E (pt) | Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados | |
| ATE266722T1 (de) | Zyklische peptidomimetische urokinaserezeptorantagonisten | |
| PT1066304E (pt) | Antagonistas macrolidos de lhrh | |
| GT199900062A (es) | Preparados efervescentes. | |
| IT1289154B1 (it) | Derivati di isoflavone loro preparazione e loro impiego terapeutico | |
| SE9803107D0 (sv) | Novel Compunds | |
| DK0814803T3 (da) | Anvendelse af steroidale estrogenreceptorantagonister til fertilitetskontrol hos mænd | |
| NO20001846L (no) | Nye farmasøytisk aktive forbindelser, deres fremstilling og anvendelse som ECE-inhibitorer |